Clover Biopharmaceuticals, Ltd. (HKG:2197)

Clover Biopharmaceuticals Statistics

Total Valuation

HKG:2197 has a market cap or net worth of HKD 2.80 billion. The enterprise value is 2.38 billion.

Market Cap	2.80B
Enterprise Value	2.38B

Important Dates

The next estimated earnings date is Wednesday, November 26, 2025.

Earnings Date	Nov 26, 2025
Ex-Dividend Date	n/a

Share Statistics

HKG:2197 has 1.30 billion shares outstanding. The number of shares has increased by 0.63% in one year.

Current Share Class	1.30B
Shares Outstanding	1.30B
Shares Change (YoY)	+0.63%
Shares Change (QoQ)	+0.28%
Owned by Insiders (%)	20.46%
Owned by Institutions (%)	8.96%
Float	804.39M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	49.40
PB Ratio	-1.50
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-2.39
EV / Sales	42.01
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-8.82

Financial Position

The company has a current ratio of 0.26

Current Ratio	0.26
Quick Ratio	0.23
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-0.05
Interest Coverage	-548.42

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-47.64%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	77.95%
Revenue Per Employee	233,464
Profits Per Employee	-4.10M
Employee Count	300
Asset Turnover	0.04
Inventory Turnover	2.01

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +576.19% in the last 52 weeks. The beta is 3.70, so HKG:2197's price volatility has been higher than the market average.

Beta (5Y)	3.70
52-Week Price Change	+576.19%
50-Day Moving Average	2.00
200-Day Moving Average	0.74
Relative Strength Index (RSI)	47.83
Average Volume (20 Days)	21,455,661

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:2197 had revenue of HKD 56.73 million and -996.69 million in losses. Loss per share was -0.79.

Revenue	56.73M
Gross Profit	-722.55M
Operating Income	-998.78M
Pretax Income	-996.69M
Net Income	-996.69M
EBITDA	-973.25M
EBIT	-998.78M
Loss Per Share	-0.79

Balance Sheet

The company has 433.65 million in cash and 14.30 million in debt, giving a net cash position of 419.35 million or 0.32 per share.

Cash & Cash Equivalents	433.65M
Total Debt	14.30M
Net Cash	419.35M
Net Cash Per Share	0.32
Equity (Book Value)	-1.87B
Book Value Per Share	-1.44
Working Capital	-1.43B

Cash Flow

In the last 12 months, operating cash flow was -270.21 million and capital expenditures 64,651, giving a free cash flow of -270.14 million.

Operating Cash Flow	-270.21M
Capital Expenditures	64,651
Free Cash Flow	-270.14M
FCF Per Share	-0.21

Margins

Gross Margin	n/a
Operating Margin	-1,760.53%
Pretax Margin	-1,756.85%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

HKG:2197 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.63%
Shareholder Yield	-0.63%
Earnings Yield	-35.57%
FCF Yield	-9.64%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:2197 has an Altman Z-Score of -32.6 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-32.6
Piotroski F-Score	3